Matthew Price is the founder of Phosplatin Therapeutics. Phosplatin Therapeutics has raised $74M in total funding. Latest round: Series A.
Matthew Price is a co-founder and Chief Operating Officer (COO) of Phosplatin Therapeutics (now Promontory Therapeutics), a clinical-stage biotech company focused on oncology therapeutics. He has led the company's funding strategy, which has included raising $74 million in equity capital.
Full founder directory · Investor directory · Company funding database · Fundraising library